Treatment of Cerebral Histiocytosis With Low Dose of Cobimetinib: A Report of 2 Cases.

Published in: Neurology(R) neuroimmunology & neuroinflammation (2024)

This case report provides Class IV evidence. This is a single observational study without controls.

Keyphrases